The Identification and Interpretation of cis-Regulatory Noncoding Mutations in Cancer
Open Access
Abstract
In the need to characterise the genomic landscape of cancers and to establish novel biomarkers and therapeutic targets, studies have largely focused on the identification of driver mutations within the protein-coding gene regions, where the most pathogenic alterations are known to occur. However, the noncoding genome is significantly larger than its protein-coding counterpart, and evidence reveals that regulatory sequences also harbour functional mutations that significantly affect the regulation of genes and pathways implicated in cancer. Due to the sheer number of noncoding mutations (NCMs) and the limited knowledge of regulatory element functionality in cancer genomes, differentiating pathogenic mutations from background passenger noise is particularly challenging technically and computationally. Here we review various up-to-date high-throughput sequencing data/studies and in silico methods that can be employed to interrogate the noncoding genome. We aim to provide an overview of available data resources as well as computational and molecular techniques that can help and guide the search for functional NCMs in cancer genomes.Keywords
Funding Information
- Medical Research Council (MR/N014308/1)
- Cancer Research UK (C16420/A18066)
This publication has 107 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elementsCellular and Molecular Life Sciences, 2012
- Repetitive DNA and next-generation sequencing: computational challenges and solutionsNature Reviews Genetics, 2011
- ChIP-Seq: technical considerations for obtaining high-quality dataNature Immunology, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- RNA sequencing: advances, challenges and opportunitiesNature Reviews Genetics, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Chromatin Modifications and Their FunctionCell, 2007
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005